Type V Collagen in Health, Disease, and Fibrosis

Anatomical Record

Volumn 299, Issue 5, 2016, Pages 613-629

  Mak, Ki M ^a   Png, Chien Yi M ^a   Lee, Danielle J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Collagen V deficiency and overexpression; Collagen V in disease and fibrosis; Collagen V neoepitopes; Collagen V synthesis and degradation; Hepatic fibrosis biomarker

Indexed keywords

ANTIFIBROTIC AGENT; BIOLOGICAL MARKER; COLLAGEN TYPE 1; COLLAGEN TYPE 5; FIBRILLAR COLLAGEN; GELATINASE; GELATINASE A; GROWTH FACTOR; MATRIX METALLOPROTEINASE; METALLOPROTEINASE; STRUCTURAL PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA;

ADIPOSE TISSUE; ALPHA CHAIN; AMINO TERMINAL SEQUENCE; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CELL FUNCTION; COLLAGEN FIBRIL; CORNEA STROMA; DISEASES; EHLERS DANLOS SYNDROME; ENZYMATIC DEGRADATION; EXPERIMENTAL LIVER FIBROSIS; EXTRACELLULAR MATRIX; FIBROSIS; GENE EXPRESSION; GRANULATION TISSUE; HEALTH; HUMAN; INFLAMMATION; KIDNEY; KIDNEY FIBROSIS; LIVER FIBROSIS; LUNG; LUNG FIBROSIS; MACROMOLECULE; MESENCHYME CELL; MICROFILAMENT; NEOPLASM; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; SKIN; TISSUE DISTRIBUTION; UPREGULATION; METABOLISM; PATHOLOGY;

COLLAGEN TYPE V; DISEASE; EXTRACELLULAR MATRIX; FIBROSIS; HUMANS;

EID: 84962513784     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.23330     Document Type: Article

References (130)

1. Adachi E, Hayashi T. 1986. In vitro formation of hybrid fibrils of type V collagen and type I collagen. Limited growth of type I collagen into thick fibrils by type V collagen. Connect Tissue Res 14:257-266.
2. Adachi E, Hayashi T, Hashimoto PH. 1991. A comparison of the immunofluorescent localization of collagen types I, III, and V with the distribution of reticular fibers on the same liver sections of the snow monkey (Macaca fuscata). Cell Tissue Res 264:1-8.
3. Alitalo K, Myllyla R, Sage H, Fritzl P, Vaheri A, Bornstein P. 1982. Biosynthesis of type V procollagen by A204, a human rhabdomyosarcoma cell line. J Biol Chem 257:9016-9024.
4. Andrikopoulos K, Liu X, Kenne DR, Jaenisch R, Ramirez F. 1995. Targeted mutation in the col5a2 gene reveals a regulatory role for type V collagen during matrix assembly. Nat Genet 9:31-36.
5. Arthur MJ. 1995. Collagenase and liver fibrosis. J Hepato 22:43-48.
6. Aycock RS, Seyer JM. 1989. Collagens of normal and cirrhotic human liver. Connect Tissue Res 23:19-31.
7. Barsky SH, Rao CN, Grotendorst Liotta LA. 1982. Increased content of type V collagen in desmoplasia of human breast carcinoma. Am J Pathol 108:276-283.
8. Baldock C, Sherratt MJ, Shuttleworth CA, Kielty CM. 2003. The supramolecular organization of collagen VI microfibrils. J Mol Biol 330:297-307.
9. Becker J, Schuppan D, Rabanu JP, Raucher R, Niechoy U, Gelderblom HR. 1991. Immunoelectron microscopic localization of collagens type I, V, VI and of procollagen type III in human periodontal ligament and cementum. J Histochem Cytochem 39:103-110.
10. 1 in tubulointerstitial cell models. Nephrol Dial Transplant 13:573-579.
11. Bezerra MC, Teodoro WR, de Oliveira CC, Velosa AP, Ogido LT, Gauditano G, Parra ER, Capelozzi VL, Yoshinari NH. 2006. Scleroderma like remodeling induced by type V collagen. Arch Dermatol Res 298:51-57.
12. Biempica L, Morecki R, Wu CH, Giambrone M-A, Rojkind M. 1980. Immunocytochemical localization of type B collagen. A component of basement membrane in human liver. Am J Pathol 98:591-602.
13. Birk DE, Fitch JM, Babiarz JP, Linsenmayer TE. 1988. Collagen type I and type V are present in the same fibril in the avian corneal stroma. J Cell Biol 106:999-1008.
14. Birk DE, Fitch JM, Babiarz JP, Doane KJ, Linsenmayer TF. 1990. Collagen fibrillogenesis in vitro: interaction of types I and V collagen regulates fibril diameter. J Cell Sci 95:649-657.
15. Birk DE. 2001. Type V collagen: heterotypic type 1/V collagen interactions in the regulation of fibril assembly. Micron 32:223-237.
16. Birk DE, Bruckner P. 2011. Collagens, suprastructures and collagen fibril assembly. In: Mecahm RP, editor. The extracellular matrix: An overview. New York: Springer-Verlag. Vol. 1: p 77-115.
17. Bobadilla JL, Love RB, Jankowska-Gan E, Xu Q, Haynes LD, Braun RK, Hayney MS, Munoz del Rio A, Meyer K, Greenspan DS, etal. 2008. Monokines, collagen type V, and primary graft dysfunction in lung transplantation. Am J Respir Crit Care Med 177:660-668.
18. Bonod-Bidaud C, Roulet M, Hansen U, Ahmed Elsheikh A, Malbouyres M, Ricard-Blum S, Faye C, Vaganay E, Rousselle P, Florence Ruggiero F. 2012. In vivo vvidence for a bridging role of a collagen V subtype at the epidermis-dermis interface. J Invest Dermatol 132:1841-1849.
19. Braun RK, Martin A, Shah S, Iwashima M, Medina Byrne K, Sethupathi P, Wigfield CH, Brand DD Love RB. 2010. Inhibition of bleomycin-induced pulmonary fibrosis through pre-treatment with collagen type V. J Heart Lung Transplant 29:873-880.
20. Broek DL, Madri J, Eikenberry EF, Brodsky B. 1985. Characterization of the tissue form of type V collagen from chick bone. J Biol Chem 260:555-562.
21. Bruels RGM, Klumpers DD, Everts V, Smit TH. 2009. Collagen type V modulates fibroblasts behavior dependent on substrate stiffness. Biochem Biophys Res Commun 380:425-429.
22. Burgeson RE, Adli FA, Kaitila II, Hollister DW. 1976. Fetal membrane collagens: identification of two new collagen alpha chains. Proc Natl Acad Sci 73:2579-2583.
23. Callado MR, Viana VS, Vendramini MB, Leon ET, Bueno C, Velosa AP, Teodoro WR, Yoshinari NH. 2007. Autoantibody profile in the experimental model of scleroderma induced by type V human collagen. Immunology 122:38-46.
24. Cao Q, Mak KM, Lieber CS. 2002. DLPC decreases TGF-β1-induced collagen mRNA by inhibiting p38 MAPK in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 283:G1051-G1060.
25. Chanut-Delalande H, Fichard A, Bernocco S, Garrone R, Hulmes DJS, Ruggiero F. 2001. Control of heterotypic fibril formation by collagen V is determined by chain stoichiometry. J Biol Chem 276:24352-24359.
26. Chanut-Delalande H, Bonod-Bidaud C, Cogne S, Malbouyres M, Ramirez F, Fichard A, Ruggiero F. 2004. Development of a functional skin matrix requires deposition of collagen V heterotrimers. Mol Cell Biol 24:6049-6057.
27. Choe I, Aycock RS, Raghow R, Myers JC, Seyer JM, Kang AH. 1987. A hepatic fibrogenenic factor stimulates the synthesis of types I, III, and V procollagen in cultured cells. J Biol Chem 262:5408-5413.
28. Chung E, Rhodes RK, Miller EJ. 1976. Isolation of three collagenous components of probable basement membrane origin from several tissues. Biochem Biophys Res Commun 71:1167-1174.
29. Dart ML, Jankowska-Gan E, Huang G, Roenneburg DA, Keller MR, Torrealba JR, Rhoads A, Kim B, Bobadilla JL, Haynes LD, etal. 2010. Interleukin-17-dependent autoimmunity to collagen type V in atherosclerosis. Circ Res 107:1106-1116.
30. Fallatah HI. 2014. Noninvasive biomarkers of liver fibrosis: an overview. Hindawi Publishing Corp. Advances in Hepatology 357287:15.
31. Fessler LI, Brosh S, Chapin S, Fessler JH. 1986a. Tyrosine sulfation in precursors of collagen V. J Biol Chem 261:5034-5040.
32. Fessler LI, Chapin S, Brosh S, Fessler JH. 1986b. Intracellular transport and tyrosine sulfation of procollagens V. Eur J Biochem 158:511-518.
33. Fichard A, Kleman JP, Ruggiero F. 1994. Another look at collagen V and Xl molecules. Matrix Biol 14:515-531.
34. Fischer H, Stenling R, Rubio C, Lindblom A. 2001. Colorectal carcinogenesis is associated with stromal expression of CLO11A1 and COL5A2. Carcinogenesis 22:875-878.
35. Fitch JM, Gross J, Mayne R, Johnson-Wint B, Linsenmayer TF. 1984. Organization of collagen types I and V in the embryonic chicken cornea: monoclonal antibody studies. PNAC 81:2791-2795.
36. Fitch JM, Birk DE, Mentzer A, Karen A, Hasty KA, Mainardi C, Linsenmayer TF. 1988. Corneal collagen fibrils: dissection with specific collagenases and monoclonal antibodies. J Biol Chem 29:1125-1136.
37. Fukoda K, Koshihara Y, Oda H, Ohyama M, Ooyama T. 1988. Type V collagen selectively inhibits human endothelial cell proliferation. Biochem Biophys Res Cimmun 152:1060-1068.
38. Gelse K, Poschl E, Aigner T. 2003. Collagens-structure, function, and biosynthesis. Advanced Drug Delivery Reviews 55:1531-1546.
39. Genovese F, Manresa AA, Leeming DJ, Karsdal MA, Boor P. 2014. The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis. Fibrogenesis Tissue Repair 7:4.
40. Gopalakrishnan B, Wang WM, Greenspan DS. 2004. Biosynthetic processing of the pro-α1 (V)pro-α2(V)pro-α3(V) procollagen heterotrimer. J BIol Chem 279:30904-30912.
41. Greenspan DS, Cheng W, Hoffman GG. 1991. The Pro-α1(V) collagen chain. Complete primary structure, distribution of expression, and comparison with the pro-αl(X1) collagen chain. J Biol Chem 266:24727-24733.
42. Gressner OA, Weiskirchen R, Gressner AM. 2007. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Clin Chim Acta 381:107-113.
43. Haralson MA, Mitchell WM, Rhodes RK, Kresina TF, Gay R, Miller EJ. 1980. Chinese hamster lung cells synthesize and confine to the cellular domain a collagen composed solely of B chains. Proc Natl Acad Sci USA 77:5206-5210.
44. Haralson MA, Mitchell WM, Rhodes RK, Kresina TF, Miller EJ. 1984. Evidence that the collagen in the culture medium of Chinese hamster lung cells contains components related at the primary structural level to the αl(V) collagen chain. Arch Biochem Biophys 229:509-518.
45. Hashimoto Y, Shieh T-Y, Aoyama H, Izawa Y, Hayakawa T. 1986. Isolation and characterization of type V collagen from human post-burn granulation tissues. J Invest Dermatol 1986; 87:540-543.
46. Henegar C, Tordjman J, Achard V, Lacasa D, A, Stich V, Viguerie N, Langin D, Bedossa P, Cremer I, Guerre-Millo M, Poitou C, Basdevant Zucker JD, Clement K. 2008. Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol 9:R14.
47. Henkel W, Dreisewerd K. 2007. Cyanogen bromide peptides of the fibrillar collagens I, III, and V and their mass spectrometric characterization: detection of linear peptides, peptide glycosylation, and cross-linking peptides involved in formation of homo- and heterotypic fibrils. J Proteome Res 6:4269-4289.
48. Hibbs MS, Hasty KA, Seyer JM, Kang AH, Mainardi CL. 1985. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem 260:2493-2500.
49. Hibbs MS, Hoidal JR, Kang AH. 1987. Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages. J Clin Invest 80:1644-1650.
50. Hirai S, Ohyane C, Kim Y-I, Lin S, Goto T, Takahashi N, Kim C-S, Kang J, Yu R, Kawada T. 2014. Involvement of mast cells in adipose tissue fibrosis. Am J Physiol Endocrinol Metab 306:E247-E255.
51. Huang G, Ge G, Wang D, Gopalakrishnan B, Butz DH, Colman RJ, Nagy A, Greenspan DS. 2011. 3(V) collagen is critical for glucose homeostasis in mice due to effects in pancreatic islets and peripheral tissues. J Clin Invest 121:769-783.
52. Huang G, Greenspan DS. 2012. ECM roles in the function of metabolic tissues. Trends Endocrinol Metab 23:16-22.
53. Imamura Y, Scott IC, Greenspan DS. 2000. The pro-α3(V) collagen chain. Complete primary structure, expression domains in adult and developing tissues and comparison to the other types V and XI procollagen chains. J Biol Chem 275:8749-8759.
54. Inkinen K, Wolff H, von Boguslawski K, Ahonen J. 1998. Type V collagen in experimental granulation tissue. Connect Tissue Res 39:281-294.
55. Kahai S, Vary CPH, Gao Y, Seth A. 2004. Collagen, type V, α1(COL5A1) is regulated by TGF-β in osteoclasts. Matrix Biol 23:445-455.
56. Karsdal MA, Henriksen K, Leeming DJ, Mitchell P, Duffin K, Barascuk N, Klickstein L, Aggarwal P, Nemirovskiy O, Byrjalsen I, Qvist P, Bay-Jensen AC, Dam EB, Madsen SH, Christiansen C. 2009. Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development. Biomarkers 4:181-202.
57. Karsdal MA, Delvin E, Christiansen C. 2011. Editorial protein fingerprints - Relying on and understanding the information of serological protein measurements. Clin Biochem 44:1278-1279.
58. Katsuda S, Okada Y, Minamoto T, Oda Y Matsui Y., Nakanishi 1992. Collagens in human atherosclerosis. Immunohistochemical analysis using collagen type-specific antibodies. Arterioscl Thromb 12:494-502.
59. Kern G, Mair SM, Noppert S-J, Jennings P, Schramek H, Rudnicki M, Mueller GA, Mayer G, Koppelstaetter C. 2014. Tacrolimus increases Nox4 expression in human renal fibroblasts and induces fibrosis-related genes by aberrant TGF-beta receptor signalling. PLoS One 9:e96377.
60. Kihara T, Imamura Y, Takemura Y, Mizuno K, Adachi E, Hayashi T. 2008. Intercellular accumulation of type V collagen fibrils in accordance with cell aggregation. J Biochem 144:625-633.
61. Kobayashi M, Nakatsukasa H, Watanabe A, Yamauchi Y, Fujiwara M, Hashimoto M, Watanabe M, Higashi T, Nagashima H. 1986. Detection of type V collagen-degrading enzyme activity in human liver. Acta Med Okayama 40:179-182.
62. Kobayasi T, Karismark T. 2006. Type V and VI collagen for cohesion of dermal fibrillar structures. J Submicrosc Cyto Pathol 38:103-108.
63. Konomi H, Hayashi T, Nakayasu K, Arima M. 1984. Localization of type V collagen and type IV collagen in human cornea, lung and skin. Immunohistochemical evidence by anti-collagen antibodies characterized by immunoelectroblotting. Am J Pathol 116:417-426.
64. Knupp C, Squire JM. 2005. Molecular packing in network-forming collagens. Adv Protein Chem 70:375-403.
65. Lawrence R, Hartmann DJ, Sonenshein GE. 1994. Transforming growth factor β1 stimulates type V collagen expression in bovine vascular smooth muscle cells. J Biol Chem 269:9603-9609.
66. Leeming DJ, Jannie M, Sand JM, Mette J, Nielsen MJ, Genovese F, Martinez FJ, Hogaboam CM, Han MK, Klickstein LB, etal. 2012. Serological investigation of the collagen degradation profile of patients with chronic obstructive pulmonary disease or idiopathic pulmonary fibrosis. Biomark Insights 7:119-126.
67. Leeming DJ, Byrjalsen I, Jimenez W, Christiansen C, Karsdal MA. 2013. Protein fingerprinting of the extracellular matrix remodelling in a rat model of liver fibrosis - a serological evaluation. Liver Int 33:439-447.
68. Lieber CS, Weiss DG, Paronetto F, For the VA Cooperative Study 391 Group. 2008. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease. Alcohol Clin Exp Res 32:1031-1039.
69. Linsenmayer TF, Fitch JM, Schmid TM, Zak NB, Gibney E, Sanderson RD, Mayne R. 1983. Monoclonal antibodies against chicken type V collagen production, specificity, and use for immunocytochemical localization in embryonic cornea and other organs. J Cell Biol 96:124-132.
70. Linsenmayer TF, Firch JM, Mayne R. 1984. Extracellular matrices in the developing avian eye: type V collagen in corneal and noncorneal tissues. Invest Ophthalmol Vis Sci 25:41-47.
71. 2-terminal domain, a putative regulator of corneal fibrillogenesis. J Cell Biol 121:1181-1189.
72. Liu T, Wang X, Morten A, Karsdal MA, Leeming DJ, Genovese F. 2012. Molecular serum markers of liver fibrosis. Biomark Insights 7:105-117.
73. Lui VCH, Kong RYC, Nicholis J, Cheung ANY, Cheah KSE. 1995. The mRNAs for the three chains of human collagen type Xl are widely distributed but not necessarily co-expressed: implications for homotrimeric, heterotrimeric and heterotypic collagen molecules. Biochem J 311:511-516.
74. Mainardi CL, Hibbs MS, HASTY KA, Seyer JM. 1984. Purification of a type V collagen degrading metalloproteinase from rabbit alveolar macrophages. Coll ReI Res 4:479-492.
75. Mak KM, Kwong AJ, Chu E, Hoo NM. 2012. Hepatic steatosis, fibrosis, and cancer in elderly cadavers. Anat Rec 295:40-50.
76. Mak KM, Sehgal P, Harris CK. 2014. Type VI collagen: its biology and value as a biomarker of hepatic fibrosis. Austin Biomark Diagn 1:9.
77. Mak KM. 2015. Codistribution of collagens V and VI with collagens I and III in hepatic fibrosis of elderly cadavers. FASEB J 29:544.4.
78. Malfait F, Wenstrup RJ, De Paepe A. 2010. Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type. Genet Med 12:597-605.
79. Marian B, Danner MW. 1987. Skin tumor promotion is associated with increased type V collagen content in the dermis. Carcinogenesis 8:151-154.
80. Martin P, Teodoro WR, Velosa AP, de Morais J, Carrasco S, Christmann RB, Goldenstein-Schainberg C, Parra ER, Katayama ML, Sotto MN, etal. 2012. Abnormal collagen V deposition in dermis correlates with skin thickening and disease activity in systemic sclerosis. Autoimmun Rev 11:827-835.
81. Martinez-Hernandez A, Gay S, Miller EJ. 1982. Ultrastructural localization of type V collagen in rat kidney. J Cell Biol 92:343-349.
82. McLaughlin JS, Linsenmayer TF, Birk DE. 1989. Type V collagen synthesis and deposition by chicken embryo corneal fibroblasts in vitro0. J Cell Sci 94:371-379.
83. Minary-Jolandan M, Yu MF. 2009. Nanomechanical heterogeneity in the gap and overlap regions of type I collagen fibrils with implications for bone heterogeneity. Biomacromolecules 10:2565-2570.
84. Miner JH. 2011. Basement membranes. In: Mecahm RP, editor. The extracellular matrix: An overview. New York: Springer-Verlag. Vol. 1, p 117-145.
85. Modesti A, Kalebic T, Scarpa S, Togo S, Grotendorst G, Liotta LA, Triche TJ. 1984. Type V collagen in human amnion is a 12 nm fibrillar component of the pericellular interstitium. Eur J Cell Biol 35:246-255.
86. Moriya K, Bae E, Honda K, Sakai K, Sakaguchi T, Tsujimoto I, Kamisoyama H, Keene DR, Sasaki T, Sakai T. 2011. A fibronectin-independent mechanism of collagen fibrillogenesis I adult liver remodeling. Gastroenterology 140:1653-1663.
87. Morton LF, Barnes MJ. 1982. Collagen polymorphism in normal and diseased blood vessel wall. Atherosclerosis 42:41-51.
88. Narayanan AS, Page RC. 1983. Biosynthesis and regulation of type V collagen in diploid human fibroblasts. J Biol Chem 258:11694-11699.
89. Niyibizi C, Fietzeks PP, van der Rest M. 1984. Human placenta type V collagens. Evidence for the existence of an αl(V)α2(V)α3(V) collagen molecule. J Biol Chem 259:14170-14174.
90. Niyibizi C, Chan R, Wu JJ, Eyre D. 1994. A 92 kDa gelatinase (MMP-9) cleavage site in native type V collagen. Biochem Biophys Res Commun 202:328-333.
91. Ooshima A. 1981. Collagen alpha B chain: increased proportion in atherosclerosis. Science 13:666-668.
92. Parra ER, Teodoro WR, Velosa APP, de Oliveira CC, Yoshinari NH, Capelozzi VL. 2006. Interstitial and vascular type V collagen morphologic disorganization in usual interstitial pneumonia. J Histocehm Cytochem 54:1315-1325.
93. Parra ER, Aguiar ACJ, Teodoro WR, de Souza R, Yoshinari NH, Capelozzi VL. 2009. Collagen V and vascular injury promote lung architectural changes in systemic sclerosis. Clin Respir J 3:135-142.
94. Parra ER, Teodoro WR, de Morais J, Katayama MLH, de Souza R, Yoshinari NH, Capelozzi VL. 2010. Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis. Eur J Clin Invest 40:110-120.
95. Rada JA, Cornuet PK, Hassell JR. 1993. Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins. Exp Eye Res 56:635-648.
96. Rojkind M, Giambrone M-A, Biempica L. 1979. Collagen types in normal and cirrhotic liver. Gastroenterology 76:710-719.
97. Rojkind M, Ponce-Noyola P. 1982. The extracellular matrix of the liver. Collagen Rel Res 2:151-175.
98. Rojkind M, Perez-Tamayo R. Liver fibrosis. 1983. In: Hall DA, Jackson DS, editors. International review of connective tissue research. Academic Press. Vol. 10, p 333-382.
99. Roulet M, Ruggiero F, Karsenty G, LeGuellec D. 2007. A comprehensive study of the spatial and temporal expression of the col5a1 gene in mouse embryos: a clue for understanding collagen V function in developing connective tissue. Cell Tissue Res 327:323-332.
100. Ruggiero F, Champliaud MF, Garrone R, Aumailley M. 1994. Interactions between cells and collagen V molecules or side chains involve distinct mechanisms. Exp Cell Res 210:215-223.
101. Schierwagen R, Leeming DJ, Klein S, Granzow M, Nielsen MJ, Sauerbruch T, Krag A, Karsdal MA, Trebicka J. 2013. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Front Physiol 4:195.
102. Schuppan D, Becker J, Boehm H, Hahn EG. 1986. Immunofluorescent localization of type V collagen as a fibrillar component of the interstitial connective tissue of human oral mucosa, artery and liver. Cell Tissue Res 243:535-543.
103. Schuppan D. 1990. Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteins. Sem Liver Dis 10:1-10.
104. Schuppan D, Ruehl M, Somasundaram R, Hahn EG. 2001. Matrix as a modulator of hepatic fibrogenesis. Sem Liver Dis 21:351-372.
105. Schwarze U, Atkinson MM, Hoffman GG, Greenspan DS, Byers PH. 2000. Null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers-Danlos syndrome (types I and II). Am J Hum Genet 66:1757-1765.
106. Scott JE, Bosworth TR, Cribb AM, Gressner AM. 1994. The chemical morphology of extracellular matrix in experimental rat. Virchows Archiv 424:89-98.
107. Sebastiani G, Alberti A. 2006. Noninvasive fibrosis biomarkers reduce but not substitute the need for liver biopsies. World J Gastroenterol 12:3682-3694.
108. Silver MH, Murray JC, Pratt RM. 1984. Epidermal growth factor stimulates type-V collagen synthesis in cultured murine palatal shelves. Differentiation 27:205-208.
109. Spencer M, Yao-Borengasser A, Unal R, Rasouli N, Gurley CM, Zhu B, Peterson CA, Kern PA. 2010. Adipose tissue macrophages in insulin-resistant subjects are associated with collagenVI and fibrosis and demonstrates alternative activation. Am J Physiol Endocrinol Metab 299:E1016-E1027.
110. Spencer M, Unal R, Zhu B, Rasouli N, McGehee REJ, Peterson CA, Kern PA. 2011. Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance. J Clin Endocrinol Metab 96:E1900-E1998.
111. Sun M, Chen S, Adams SM, Florer JB, Liu H, Kao WWY, Wenstrup RJ, Birk DE. 2011. Collagen V is a dominant regulator of collagen fibrillogenesis: dysfunctional regulation of structure and function in a corneal-stroma-specific Col5a1-null mouse model. J Cell Sci 124:4096-4105.
112. Symoens S, Renard M, Bonod-Bidaud C, Syx D, Vaganay E, Malfait F, Ricard-Blum S, Kessler E, Van Lear L, Coucke P, et al. 2011. Identification of binding partners interacting with the α1-N-propeptide of type V collagen. Biochem J 433:371-381.
113. Symoens S, Syx D, Malfait F, Callewaert B, De Backer J, Vanakker O, Coucke P, De Paepe A. 2012. Comprehensive molecular analysis demonstrates type V collagen mutations in over 90% of patients with classic EDS and allows to refine diagnostic criteria. Hum Mutat 33:1485-1493.
114. Takahara K, Sato Y, Okazawa K, Okamoto N, Noda A, Vaoi Y, Kato I. 1991. Complete primary structure of human collagen α1(V) chain. J Biol Chem 266:13124-13129.
115. Takai KK, Hattori S, Irie S. 2001. Type V collagen distribution in liver is reconstructed in coculture system of hepatocytes and stellate cells; the possible functions of type V collagen in liver under normal and pathological conditions. Cell Struct Function 26:289-302.
116. Teodoro WR, Velosa AP, Witzel SS, Garippo AL, Farhat C, Parra ER, Sonohara S, Capelozzi VL, Yoshinari NH. 2004. Architectural remodeling in lungs of rabbits induced by type V collagen immunization: a preliminary morphologic model to study diffuse connective tissue diseases. Pathol Res Pract 200:681-691.
117. 2pro-α2(V) collagen heterotrimer by bone morphogenetic protein-1 and furin-like proprotein convertases. J Biol Chem 277:5596-5602.
118. Vassiliadis E, Veidal SS, Simonsen H, Larsen DV, Vainer B, Chen X, Zheng Q, Karsdal MA, Leeming DJ. 2011. Immunological detection of the type V collagen propeptide fragment, PVCP-1230, in connective tissue remodeling associated with liver fibrosis. Biomarkers 16:426-433.
119. Vassiliadis E, Veidal SS, Hansen C, Karsdal MA, Leeming DJ. 2012. Circulating levels of a collagen type V propeptide fragment in a carbon tetrachloride reversible model of liver fibrosis. Biomark Insights 7:159-166.
120. Vassiliadis E, Barascuk N, Karsdal MA. 2013. Atherofibrosis - a unique and common process of the disease pathogenesis of atherosclerosis and fibrosis - lesions for biomarker development. Am J Transl Res 5:1-14.
121. Vittal R, Mickler EA, Fisher AJ, Zhang C, Rothhaar K, Gu H, Krista M, Brown KM, Emtiazdjoo A, Lott JM, etal. 2013. Type V collagen induced tolerance suppresses collagen deposition, TGF-ß and associated transcripts in pulmonary fibrosis. PLoS One 8:e76451.
122. Vleming LJ, Baelde JJ, Westendorp RG, Daha MR, van Es LA, Bruijn JA. 1995. Progression of chronic renal disease in humans is associated with the deposition of basement membrane components and decorin in the interstitial extracellular matrix. Clin Nephrol 44:211-219.
123. Voss B, Rauterburg J, Allam S, Port G. 1980. Distribution of collagen type I and type III and of two collagenous components of basement membranes in the human liver. Path Res Pract 170:50-60.
124. Wenstrup RJ, Florer JB, Eric W, Brunskill EW, Bell SM, Chervoneva I, Birk DE. 2004. Type V collagen controls the initiation of collagen fibril assembly. J Biol Chem 279:53331-53337.
125. Wenstrup RJ, Florer JB, Davidson JM, Phillips CL, Pfeiffer BJ, Menezes DW, Chervoneva I, Birk DE. 2006. Murine model of the Ehlers-Danlos syndrome: col5a1 haploinsufficiency disrupts collagen fibril assembly at multiple stages. J Biol Chem 281:12888-12895.
126. Woodbury D, Benson-Chanda V, Ramirez F. 1989. Amino-terminal propeptide of human pro-α2(V) collagen conforms to the structural criteria of a fibrillar procollagen molecule. J Biol Chem 264:2735-2738.
127. Yamamoto M, Sumiyoshi H, Nakagami K, Tahara E. 1984. Distribution of collagen types I, III, and V in fibrotic and neoplastic human liver. Acta Pathol Jap 34:77-86.
128. Yamamoto K, Yamamoto M, Noumura T. 1992. Disassembly of F-actin in human endothelial cells cultured on type V collagen. Exp Cell Res 201:55-63.
129. Yasufuku K, Heidler KM, Woods KA, Smith GNJ, Cummings OW, Fujisawa T, Wilkes DS. 2001. Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance. Am J Respir Cell Mol Biol 25:26-34.
130. Zhang G, Chen S, Goldoni S, Calder BW, Simpson HC, Owens RT, McQuillan D, Young MF, Renato V, Iozzo R, etal. 2009. Genetic evidence for the coordinated regulation of collagen fibrillogenesis in the cornea by decorin and biglycan. J Biol Chem 284:8888-8897.